Triple-negative breast cancers (TNBCs) refer to describe those cancers which do not express oestrogen receptor (ER), progesterone receptor (PR) or overexpress human epidermal growth factor receptor 2 (Her2/neu) [1]. This evidence concerns the gene PGR and triple-negative breast carcinoma.